New Therapy Approved for Hodgkin's Lymphoma

Dr. Anas Younes, with the MD Anderson Cancer Center, talks about the approval of brentuximab vedotin for Hodgkin's lymphoma; currently available for patients with advanced stage Hodgkin's lymphoma

LymphomaInfo Social